187 related articles for article (PubMed ID: 33403025)
21. Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis.
Tu Y; Wang Z; Wang X; Yang H; Zhang P; Johnson M; Liu N; Liu H; Jin W; Zhang Y; Cui D
Am J Transl Res; 2016; 8(6):2803-11. PubMed ID: 27398163
[TBL] [Abstract][Full Text] [Related]
22. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence.
Rai P; Young JJ; Burton DG; Giribaldi MG; Onder TT; Weinberg RA
Oncogene; 2011 Mar; 30(12):1489-96. PubMed ID: 21076467
[TBL] [Abstract][Full Text] [Related]
23. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes.
Lin YT; Liu W; He Y; Wu YL; Chen WN; Lin XJ; Lin X
Cell Physiol Biochem; 2018; 51(1):80-96. PubMed ID: 30448843
[TBL] [Abstract][Full Text] [Related]
25. Targeting the nucleic acid oxidative damage repair enzyme MTH1: a promising therapeutic option.
Ding Y; Liu Q
Front Cell Dev Biol; 2024; 12():1334417. PubMed ID: 38357002
[TBL] [Abstract][Full Text] [Related]
26. Expression of Cytoplasmic 8-oxo-Gsn and MTH1 Correlates with Pathological Grading in Human Gastric Cancer.
Song WJ; Jiang P; Cai JP; Zheng ZQ
Asian Pac J Cancer Prev; 2015; 16(15):6335-8. PubMed ID: 26434839
[TBL] [Abstract][Full Text] [Related]
27. Identification and structure-activity relationship of purine derivatives as novel MTH1 inhibitors.
Kumar A; Kawamura T; Kawatani M; Osada H; Zhang KYJ
Chem Biol Drug Des; 2017 Jun; 89(6):862-869. PubMed ID: 27863017
[TBL] [Abstract][Full Text] [Related]
28. Investigation of micronucleus induction in MTH1 knockdown cells exposed to UVA, UVB or UVC.
Fotouhi A; Cornella N; Ramezani M; Wojcik A; Haghdoost S
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():161-5. PubMed ID: 26520386
[TBL] [Abstract][Full Text] [Related]
29. Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase.
Nakabeppu Y; Oka S; Sheng Z; Tsuchimoto D; Sakumi K
Mutat Res; 2010 Nov; 703(1):51-8. PubMed ID: 20542142
[TBL] [Abstract][Full Text] [Related]
30. Hypoxic Signaling and the Cellular Redox Tumor Environment Determine Sensitivity to MTH1 Inhibition.
Bräutigam L; Pudelko L; Jemth AS; Gad H; Narwal M; Gustafsson R; Karsten S; Carreras Puigvert J; Homan E; Berndt C; Berglund UW; Stenmark P; Helleday T
Cancer Res; 2016 Apr; 76(8):2366-75. PubMed ID: 26862114
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML.
Centio A; Estruch M; Reckzeh K; Sanjiv K; Vittori C; Engelhard S; Warpman Berglund U; Helleday T; Theilgaard-Mönch K
Mol Cancer Ther; 2022 May; 21(5):703-714. PubMed ID: 35247918
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of Escherichia coli (MutT) and human (MTH1) 8-oxo-dGTPases to in vitro inhibition by the carcinogenic metals, nickel(II), copper(II), cobalt(II) and cadmium(II).
Porter DW; Yakushiji H; Nakabeppu Y; Sekiguchi M; Fivash MJ; Kasprzak KS
Carcinogenesis; 1997 Sep; 18(9):1785-91. PubMed ID: 9328176
[TBL] [Abstract][Full Text] [Related]
33. Role of As3mt and Mth1 in the genotoxic and carcinogenic effects induced by long-term exposures to arsenic in MEF cells.
Barguilla I; Peremartí J; Bach J; Marcos R; Hernández A
Toxicol Appl Pharmacol; 2020 Dec; 409():115303. PubMed ID: 33141059
[TBL] [Abstract][Full Text] [Related]
34. A molecular basis for the selective recognition of 2-hydroxy-dATP and 8-oxo-dGTP by human MTH1.
Sakai Y; Furuichi M; Takahashi M; Mishima M; Iwai S; Shirakawa M; Nakabeppu Y
J Biol Chem; 2002 Mar; 277(10):8579-87. PubMed ID: 11756418
[TBL] [Abstract][Full Text] [Related]
35. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.
Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F
EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797
[TBL] [Abstract][Full Text] [Related]
36. Expression and function of MutT homolog 1 in distinct subtypes of breast cancer.
Zhang X; Song W; Zhou Y; Mao F; Lin Y; Guan J; Sun Q
Oncol Lett; 2017 Apr; 13(4):2161-2168. PubMed ID: 28454376
[TBL] [Abstract][Full Text] [Related]
37. Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress.
Wang JY; Liu GZ; Wilmott JS; La T; Feng YC; Yari H; Yan XG; Thorne RF; Scolyer RA; Zhang XD; Jin L
Cancer Res; 2017 Nov; 77(22):6226-6239. PubMed ID: 28947420
[TBL] [Abstract][Full Text] [Related]
38. MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool.
Scaletti ER; Vallin KS; Bräutigam L; Sarno A; Warpman Berglund U; Helleday T; Stenmark P; Jemth AS
J Biol Chem; 2020 Apr; 295(15):4761-4772. PubMed ID: 32144205
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
Yokoyama T; Kitakami R; Mizuguchi M
Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603
[TBL] [Abstract][Full Text] [Related]
40. MTH1 Inhibitor TH588 Disturbs Mitotic Progression and Induces Mitosis-Dependent Accumulation of Genomic 8-oxodG.
Rudd SG; Gad H; Sanjiv K; Amaral N; Hagenkort A; Groth P; Ström CE; Mortusewicz O; Berglund UW; Helleday T
Cancer Res; 2020 Sep; 80(17):3530-3541. PubMed ID: 32312836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
